A detailed history of Squarepoint Ops LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Squarepoint Ops LLC holds 22,478 shares of OCUL stock, worth $187,241. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,478
Previous 64,911 65.37%
Holding current value
$187,241
Previous $443,000 55.98%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.45 - $9.23 $273,692 - $391,656
-42,433 Reduced 65.37%
22,478 $195,000
Q2 2024

Aug 14, 2024

BUY
$4.2 - $8.69 $199,978 - $413,765
47,614 Added 275.27%
64,911 $443,000
Q1 2024

May 15, 2024

BUY
$3.85 - $10.93 $12,909 - $36,648
3,353 Added 24.05%
17,297 $157,000
Q4 2023

Feb 14, 2024

BUY
$2.08 - $4.52 $530 - $1,152
255 Added 1.86%
13,944 $62,000
Q2 2023

Aug 14, 2023

BUY
$4.6 - $7.64 $62,969 - $104,583
13,689 New
13,689 $70,000
Q3 2022

Nov 14, 2022

SELL
$4.09 - $6.5 $80,164 - $127,400
-19,600 Reduced 53.13%
17,291 $72,000
Q2 2022

Aug 15, 2022

BUY
$3.01 - $5.22 $111,041 - $192,571
36,891 New
36,891 $148,000
Q4 2021

Feb 14, 2022

SELL
$6.16 - $12.07 $122,664 - $240,349
-19,913 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$9.7 - $14.34 $143,249 - $211,773
-14,768 Reduced 42.58%
19,913 $199,000
Q2 2021

Aug 16, 2021

BUY
$13.43 - $19.16 $196,816 - $280,789
14,655 Added 73.18%
34,681 $492,000
Q1 2021

May 17, 2021

BUY
$15.82 - $22.11 $153,628 - $214,710
9,711 Added 94.14%
20,026 $329,000
Q4 2020

Feb 16, 2021

SELL
$7.91 - $22.95 $842,660 - $2.44 Million
-106,531 Reduced 91.17%
10,315 $214,000
Q3 2020

Nov 16, 2020

SELL
$7.36 - $9.87 $238,544 - $319,896
-32,411 Reduced 21.71%
116,846 $889,000
Q2 2020

Aug 14, 2020

BUY
$4.67 - $8.95 $578,300 - $1.11 Million
123,833 Added 487.07%
149,257 $1.24 Million
Q1 2020

May 15, 2020

BUY
$3.95 - $7.4 $100,424 - $188,137
25,424 New
25,424 $126,000
Q4 2019

Feb 14, 2020

SELL
$2.57 - $4.73 $36,874 - $67,866
-14,348 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$3.04 - $5.32 $43,617 - $76,331
14,348 New
14,348 $44,000
Q1 2018

May 15, 2018

SELL
$4.66 - $7.08 $103,652 - $157,480
-22,243 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$3.73 - $6.37 $82,966 - $141,687
22,243
22,243 $99,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $641M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.